Loading...

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

BACKGROUND: The most advanced dengue vaccine candidate is a live-attenuated recombinant vaccine containing the four dengue viruses on the yellow fever vaccine backbone (CYD-TDV) developed by Sanofi Pasteur. Several analyses have been published on the safety and immunogenicity of the CYD-TDV vaccine...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Vaccine
Main Authors: Dorigatti, Ilaria, Aguas, Ricardo, Donnelly, Christl A., Guy, Bruno, Coudeville, Laurent, Jackson, Nicholas, Saville, Melanie, Ferguson, Neil M.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Science 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504002/
https://ncbi.nlm.nih.gov/pubmed/26051515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.059
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!